Which of the following is an indication for the use of raloxifene ?
**Question:** Which of the following is an indication for the use of raloxifene?
A. Prevention of osteoporosis in high-risk postmenopausal women
B. Treatment of moderate to severe hot flashes in postmenopausal women
C. Prevention of breast cancer in high-risk postmenopausal women
D. Treatment of benign prostatic hyperplasia (BPH)
**Correct Answer:** C. Prevention of breast cancer in high-risk postmenopausal women
**Core Concept:** Raloxifene is a selective estrogen receptor modulator (SERM) used to treat and prevent certain conditions related to estrogen deficiency in postmenopausal women.
**Why the Correct Answer is Right:** Raloxifene is primarily used for its estrogen-like effects on bone and breast tissue, and its antiestrogenic effects on endometrial tissue. In high-risk postmenopausal women, raloxifene can help prevent the development of breast cancer by selectively binding to estrogen receptors in breast tissue, inhibiting proliferation of estrogen-sensitive cells, and reducing the risk of breast cancer.
**Why Each Wrong Option is Incorrect:**
A. Prevention of osteoporosis in high-risk postmenopausal women is not the primary indication for raloxifene. Bisphosphonates, hormone therapy, and calcitonin are more commonly used for this purpose.
B. Treatment of moderate to severe hot flashes in postmenopausal women is not the primary indication for raloxifene. Hormone therapy, such as estrogen and progesterone, are more commonly used for this purpose.
D. Treatment of benign prostatic hyperplasia (BPH) is not an indication for raloxifene. BPH is treated with alpha-blockers, 5-alpha-reductase inhibitors, and finasteride. Raloxifene is not effective in treating BPH symptoms.
**Clinical Pearl:** Raloxifene is an effective medication in preventing breast cancer and treating osteoporosis in high-risk postmenopausal women, but it has limited use in the treatment of hot flashes and BPH. It is essential for students to understand the specific indications for raloxifene to make informed clinical decisions when prescribing this medication.